Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Expert Opinion on Therapeutic Targets|November 18, 2017
Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomasAnna Orlova, Bettina Wingelhofer, Heidi A Neubauer, et al.Cancers|December 11, 2019
Direct Targeting Options for STAT3 and STAT5 in CancerAnna Orlova, Christina Wagner, Elvin D de Araujo, et al.The Journal of Clinical Investigation|April 14, 2020
The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5Darshana Kadekar, Rasmus Agerholm, John Rizk, et al.Cancers|October 23, 2021
A Recurrent <i>STAT5B<sup>N642H</sup></i> Driver Mutation in Feline Alimentary T Cell LymphomaMatthias Kieslinger, Alexander Swoboda, Nina Kramer, et al.Cancers|November 14, 2019
Structural Implications of STAT3 and STAT5 SH2 Domain MutationsElvin D de Araujo, Anna Orlova, Heidi A Neubauer, et al.Cancers|December 10, 2021
Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate CancerRobert Wiebringhaus, Matteo Pecoraro, Heidi A Neubauer, et al.Oncogene|April 18, 2018
NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growthKhaled Seidi, Rana Jahanban-Esfahlan, Hassan Monhemi, et al.Cancer Research|July 22, 2017
CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1Wenying Zhu, Kate E Jarman, Noor A Lokman, et al.The Biochemical Journal|October 26, 2019
Kelch-like protein 5-mediated ubiquitination of lysine 183 promotes proteasomal degradation of sphingosine kinase 1Jason A Powell, Melissa R Pitman, Julia R Zebol, et al.Oncogene|September 26, 2018
Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastomaHeidi A Neubauer, Melinda N Tea, Julia R Zebol, et al.Pageof 4